Unraveling Atopic Dermatitis: Insights into Pathophysiology, Therapeutic Advances, and Future Perspectives
Cells · 28.02.2024 · 13 (5) · 425
DOI: 10.3390/cells13050425 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 28.02.2024. Verfasst von Ashutosh Pareek und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Banasthali Vidyapith, Banasthali 304022, India. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Asthma, Rhinitis, Allergic. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Atopic dermatitis (AD) is an inflammatory skin condition that frequently develops before the onset of allergic rhinitis or asthma. More than 10% of children are affected by this serious skin condition, which is painful for the sufferers. Recent research has connected the environment, genetics, the skin barrier, drugs, psychological factors, and the immune system to the onset and severity of AD. The causes and consequences of AD and its cellular and molecular origins are reviewed in this paper. The exploration of interleukins and their influence on the immunological pathway in AD has been facilitated by using relevant biomarkers in clinical trials. This approach enables the identification of novel therapeutic modalities, fostering the potential for targeted translational research within the realm of personalized medicine. This review focuses on AD’s pathophysiology and the ever-changing therapeutic landscape. Beyond the plethora of biologic medications in various stages of approval or development, a range of non-biologic targeted therapies, specifically small molecules, have emerged. These include Janus kinase (JAK) inhibitors like Baricitinib, Upadacitinib, and Abrocitinib, thus expanding the spectrum of therapeutic options. This review also addresses the latest clinical efficacy data and elucidates the scientific rationale behind each targeted treatment for atopic dermatitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Banasthali Vidyapith, Banasthali 304022, India.
- Department of Bioscience and Biotechnology, Banasthali Vidyapith, Banasthali 304022, India.
- Northdale Hospital, Department of Health, Pietermaritzburg 3200, South Africa.
- Discipline of Medical Biochemistry, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban 4041, South Africa.
ORCID-Profile: Ashutosh Pareek, Lipika Kumari, Aaushi Pareek, Simran Chaudhary, Yashumati Ratan, Pracheta Janmeda, Sanam Chuturgoon, Anil Chuturgoon
Zitieren
APA
Pareek, A., Kumari, L., Pareek, A., Chaudhary, S., Ratan, Y., Janmeda, P., Chuturgoon, S., & Chuturgoon, A. (2024). Unraveling Atopic Dermatitis: Insights into Pathophysiology, Therapeutic Advances, and Future Perspectives. Cells, 13(5), 425. https://doi.org/10.3390/cells13050425
Vancouver
Pareek A, Kumari L, Pareek A, Chaudhary S, Ratan Y, Janmeda P, et al. Unraveling Atopic Dermatitis: Insights into Pathophysiology, Therapeutic Advances, and Future Perspectives. Cells. 2024;13(5):425. doi:10.3390/cells13050425
BibTeX
@article{Pareek2024,
author = {Pareek, Ashutosh and Kumari, Lipika and Pareek, Aaushi and Chaudhary, Simran and Ratan, Yashumati and Janmeda, Pracheta and Chuturgoon, Sanam and Chuturgoon, Anil},
title = {Unraveling Atopic Dermatitis: Insights into Pathophysiology, Therapeutic Advances, and Future Perspectives},
journal = {Cells},
year = {2024},
volume = {13},
number = {5},
pages = {425},
doi = {10.3390/cells13050425}
}
EUVIMED